{"id":"https://openalex.org/W2133538529","doi":"https://doi.org/10.1021/jm800861c","title":"Synthesis, Activity, and Pharmacophore Development for Isatin-\u03b2-thiosemicarbazones with Selective Activity toward Multidrug-Resistant Cells","display_name":"Synthesis, Activity, and Pharmacophore Development for Isatin-\u03b2-thiosemicarbazones with Selective Activity toward Multidrug-Resistant Cells","publication_year":2009,"publication_date":"2009-04-27","ids":{"openalex":"https://openalex.org/W2133538529","doi":"https://doi.org/10.1021/jm800861c","mag":"2133538529","pmid":"https://pubmed.ncbi.nlm.nih.gov/19397322","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2744114"},"language":"en","primary_location":{"id":"doi:10.1021/jm800861c","doi":"https://doi.org/10.1021/jm800861c","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm800861c","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2744114","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022924056","display_name":"Matthew D. Hall","orcid":"https://orcid.org/0000-0002-5073-442X","observed_orcids":["https://orcid.org/0000-0002-5073-442X"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Matthew D. Hall","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016129593","display_name":"Noeris K. Salam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Noeris K. Salam","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063362950","display_name":"Jennifer L. Hellawell","orcid":"https://orcid.org/0000-0001-8485-1846","observed_orcids":["https://orcid.org/0000-0001-8485-1846"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Jennifer L. Hellawell","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108387951","display_name":"Henry Marshall Fales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Henry M. Fales","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005784028","display_name":"Caroline B. Kensler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Caroline B. Kensler","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065709859","display_name":"Joseph Aloysius Ludwig","orcid":"https://orcid.org/0000-0001-6631-8554","observed_orcids":["https://orcid.org/0000-0001-6631-8554"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"Joseph A. Ludwig","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017567690","display_name":"Gergely Szak\u00e1cs","orcid":"https://orcid.org/0000-0002-9311-7827","observed_orcids":["https://orcid.org/0000-0002-9311-7827"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I7597260","display_name":"Hungarian Academy of Sciences","ror":"https://ror.org/02ks8qq67","country_code":"HU","type":"government","lineage":["https://openalex.org/I7597260"]}],"countries":["AU","HU","US"],"is_corresponding":false,"raw_author_name":"Gergely Szak\u00e1cs","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","Hungarian Academy of Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Hungarian Academy of Sciences","institution_ids":["https://openalex.org/I7597260"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088845547","display_name":"David E. Hibbs","orcid":"https://orcid.org/0000-0002-2635-2990","observed_orcids":["https://orcid.org/0000-0002-2635-2990"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["AU","US"],"is_corresponding":false,"raw_author_name":"David E. Hibbs","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030334751","display_name":"Michael M. Gottesman","orcid":"https://orcid.org/0000-0001-8908-2097","observed_orcids":["https://orcid.org/0000-0001-8908-2097"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I4210106489","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210106489"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["AU","US"],"is_corresponding":true,"raw_author_name":"Michael M. Gottesman","raw_affiliation_strings":["Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Group in Biomolecular Structure and Informatics, Pharmaceutical Chemistry Division, Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia, Laboratory of Applied Mass Spectrometry, National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Sarcoma Medical Oncology, University of Texas\u2014MD Anderson Cancer Center, Houston, Texas 70030","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5030334751"],"corresponding_institution_ids":["https://openalex.org/I129604602","https://openalex.org/I1299303238","https://openalex.org/I1343551460","https://openalex.org/I4210106489","https://openalex.org/I4210140884"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":6.144,"has_fulltext":false,"cited_by_count":168,"citation_normalized_percentile":{"value":0.97330713,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"52","issue":"10","first_page":"3191","last_page":"3204"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0333000011742115,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/isatin-beta-thiosemicarbazone","display_name":"isatin-\u03b2-thiosemicarbazone","score":0.9279999732971191},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8659999966621399},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9580000042915344},{"id":"https://openalex.org/keywords/pharmacophore-modeling","display_name":"pharmacophore modeling","score":0.734000027179718},{"id":"https://openalex.org/keywords/qsar","display_name":"QSAR","score":0.8960000276565552},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.621999979019165},{"id":"https://openalex.org/keywords/bioisosteres","display_name":"bioisosteres","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.9307158589363098},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9037013649940491},{"id":"https://openalex.org/C2777256644","wikidata":"https://www.wikidata.org/wiki/Q421348","display_name":"Isatin","level":2,"score":0.8920903205871582},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.7124950289726257},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.6628644466400146},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.63800048828125},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.5990845561027527},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5863304138183594},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.5454089045524597},{"id":"https://openalex.org/C83591994","wikidata":"https://www.wikidata.org/wiki/Q416105","display_name":"Semicarbazone","level":2,"score":0.5380150675773621},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.5364165306091309},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5211972594261169},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.4924110174179077},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.4248707890510559},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.41225171089172363},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.33216530084609985},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28125447034835815},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.12656795978546143},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.07495534420013428},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003603","descriptor_name":"Cytotoxins","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D003603","descriptor_name":"Cytotoxins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007510","descriptor_name":"Isatin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007510","descriptor_name":"Isatin","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D007510","descriptor_name":"Isatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007510","descriptor_name":"Isatin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057927","descriptor_name":"Hydrophobic and Hydrophilic Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/jm800861c","doi":"https://doi.org/10.1021/jm800861c","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm800861c","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:19397322","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19397322","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2744114","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2744114","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Med Chem","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2744114","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2744114","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Med Chem","raw_type":"Text"},"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1671886256","display_name":"Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells","funder_award_id":"Z01BC005598","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5321147876","display_name":"Synthesis of  Analogues of NSC73306 to Circumvent Multidrug Resistance in Cancer","funder_award_id":"Z01HL001058","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320306082","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W92206081","https://openalex.org/W945784711","https://openalex.org/W954280178","https://openalex.org/W1486288260","https://openalex.org/W1540828223","https://openalex.org/W1578072993","https://openalex.org/W1964378600","https://openalex.org/W1966086881","https://openalex.org/W1970418317","https://openalex.org/W1977054944","https://openalex.org/W1977373583","https://openalex.org/W1977790491","https://openalex.org/W1978067320","https://openalex.org/W1978377492","https://openalex.org/W1984896504","https://openalex.org/W1985226149","https://openalex.org/W1996952787","https://openalex.org/W1999491936","https://openalex.org/W2006277511","https://openalex.org/W2006434892","https://openalex.org/W2015576599","https://openalex.org/W2017323433","https://openalex.org/W2025871899","https://openalex.org/W2049507401","https://openalex.org/W2055810949","https://openalex.org/W2055904567","https://openalex.org/W2059499441","https://openalex.org/W2065161846","https://openalex.org/W2126873719","https://openalex.org/W2128788119","https://openalex.org/W2138094292","https://openalex.org/W2150422941","https://openalex.org/W2152546397","https://openalex.org/W2153331460","https://openalex.org/W2156088967","https://openalex.org/W2169302611","https://openalex.org/W2170285778","https://openalex.org/W2171559922","https://openalex.org/W2212683988","https://openalex.org/W2339869834","https://openalex.org/W2410033415","https://openalex.org/W2444293389","https://openalex.org/W2469194024","https://openalex.org/W4211048190","https://openalex.org/W4242070356"],"related_works":["https://openalex.org/W2029280736","https://openalex.org/W2513451521","https://openalex.org/W2014261457","https://openalex.org/W2314420585","https://openalex.org/W4230484065","https://openalex.org/W2558522892","https://openalex.org/W3093938594","https://openalex.org/W2156088967","https://openalex.org/W2161197054","https://openalex.org/W7101012351"],"abstract_inverted_index":{"We":[0],"have":[1,35],"recently":[2],"identified":[3],"a":[4,39,101,109],"new":[5],"class":[6],"of":[7,41,79,86,113,119,144,146],"compounds":[8],"that":[9,13,22,107],"selectively":[10],"kill":[11],"cells":[12],"express":[14],"P-glycoprotein":[15],"(P-gp,":[16],"MDR1),":[17],"the":[18,53,67,77,83,87,90,93,117,123,139,142],"ATPase":[19],"efflux":[20],"pump":[21],"confers":[23],"multidrug":[24],"resistance":[25],"on":[26,92],"cancer":[27],"cells.":[28],"Several":[29],"isatin-beta-thiosemicarbazones":[30],"from":[31],"our":[32],"initial":[33],"study":[34],"been":[36],"validated":[37],"and":[38,44,60,89,135],"range":[40],"analogues":[42],"synthesized":[43],"tested.":[45],"A":[46],"number":[47],"demonstrated":[48],"improved":[49],"MDR1-selective":[50,74,133],"activity":[51,134],"over":[52],"lead,":[54],"NSC73306":[55],"(1).":[56],"Pharmacophores":[57],"for":[58,71,129,141],"cytotoxicity":[59,118],"MDR1":[61],"selectivity":[62],"were":[63],"generated":[64],"to":[65],"delineate":[66],"structural":[68],"features":[69,81],"required":[70],"activity.":[72],"The":[73],"pharmacophore":[75],"highlights":[76],"importance":[78],"aromatic/hydrophobic":[80],"at":[82],"N4":[84],"position":[85],"thiosemicarbazone":[88],"reliance":[91],"isatin":[94],"moiety":[95],"as":[96,126],"key":[97],"bioisosteric":[98],"contributors.":[99],"Additionally,":[100],"quantitative":[102],"structure-activity":[103],"relationship":[104],"(QSAR)":[105],"model":[106],"yielded":[108],"cross-validated":[110],"correlation":[111],"coefficient":[112],"0.85":[114],"effectively":[115],"predicts":[116],"untested":[120],"thiosemicarbazones.":[121],"Together,":[122],"models":[124],"serve":[125],"effective":[127],"approaches":[128],"predicting":[130],"structures":[131],"with":[132],"aid":[136],"in":[137],"directing":[138],"search":[140],"mechanism":[143],"action":[145],"1.":[147]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":22},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}